Penetrant Or Absorbent (enhances Penetration Into Subject Treated) Patents (Class 514/946)
-
Patent number: 6719986Abstract: The invention relates to an agent for treating skin diseases and/or functional disorders of the skin on the basis of different medicaments and/or auxiliary substances through promotion of penetration from topical formulations into the skin. According to the invention, the agent is composed of a hyaluronate lyase produced by microbial means and a medicament, preferably a hydrophilic medicament and/or auxiliary substances in different galenic formulations including colloidal carrier systems. The areas of application for the invention in human and veterinary medicament relate to the treatment, prophylaxis and/or metaphylaxis of skin diseases, functional disorders of the skin, the processes of skin ageing and dry skin conditions.Type: GrantFiled: September 5, 2001Date of Patent: April 13, 2004Assignee: esparma GmbHInventors: Wolfgang Wohlrab, Reinhard Neubert, Christoph Huschka, Peter-Jürgen Müller, Jörg-Herman Ozegowski, Dieter Koegst, Gerhard Fries
-
Patent number: 6716441Abstract: The present invention relates to a novel composition for efficiently releasing hydrophilic or water-soluble skin care actives from an oleaginous composition. The substantially oleaginous composition of the present invention comprises: (1) at least one skin care active; (2) a release agent having an HLB of at least about 3; and (3) a hydrophobic barrier protectant. The novel release composition may be topically applied to skin using a dispensing means such as an absorbent article, a wipe, a bandage, a pad, a canister, a stick, an aerosol dispenser, a sprayer, and the like.Type: GrantFiled: December 17, 1999Date of Patent: April 6, 2004Assignee: The Procter & Gamble CompanyInventors: Scott Edward Osborne, George Endel Deckner, Thomas James Klofta, Victor Nicholas Vega
-
Patent number: 6713461Abstract: This invention relates to a complex of eletriptan and a sulphobutylether-beta-cyclodextrin, or a pharmaceutically acceptable salt thereof, and to processes for the preparation of, pharmaceutical formulations including, and the uses of, such a complex.Type: GrantFiled: June 29, 2000Date of Patent: March 30, 2004Assignee: Pfizer Inc.Inventor: Anne Billotte
-
Patent number: 6706666Abstract: An enhancer composition for agricultural chemicals which can enhance the effectiveness of an agricultural chemical without causing any phytotoxicity to various crops, which comprises at least one nitrogen-containing compound selected from the group consisting of a tertiary amine, a tertiary amine salt and a quaternary ammonium salt and a chelating agent, wherein the content of the chelating agent ranges from 0.01 to 30 mol per mol of the nitrogen-containing compound.Type: GrantFiled: April 1, 1998Date of Patent: March 16, 2004Assignee: Kao CorporationInventors: Keiko Hasebe, Tadayuki Suzuki, Yuichi Hioki
-
Patent number: 6692766Abstract: The present invention relates to a controlled release drug delivery system comprising a drug which is susceptible to enzymatic degradation by enzymes present in the intestinal tract; and a polymeric matrix which undergoes erosion in the gastrointestinal tract comprising a hydrogel-forming polymer selected from the group consisting of (a) polymers which are themselves capable of enhancing absorption of said drug across the intestinal mucosal tissues and of inbihiting degradation of said drug by intestinal enzymes; and (b) polymers which are not themselves capable of enhancing absorption of said drug across the intestinal mucosal tissues and of inhibiting degradation of said drug by intestinal enzymes; wherein when the matrix comprises a polymer belonging to group (b) the delivery system further comprises an agent which enhances absorption of said drug across the intestinal mucosal tissues and/or an agent which inhibits degradation of said drug by intestinal enzymes and when the matrix comprises a polymer belonType: GrantFiled: February 28, 1997Date of Patent: February 17, 2004Assignee: Yissum Research Development Company of The Hebrew University of JerusalemInventors: Abraham Rubinstein, Raphael Radai, Michael Friedman, Boaz Tirosh, Muhammad Baluom, Taher Nassar
-
Patent number: 6673835Abstract: A viscous gel for delivering minor effective amounts of active substances through the nasal membrane into the body.Type: GrantFiled: September 1, 1999Date of Patent: January 6, 2004Assignee: Zicam LLCInventors: Charles Hensley, Robert Steven Davidson
-
Patent number: 6673363Abstract: Methods are provided for enhancing the permeability of skin or mucosal tissue to topical or transdermal application of local anesthetic agents. The methods entail the use of a base in order to increase the flux of the agent through a body surface while minimizing the likelihood of skin damage, irritation or sensitization. The permeation enhancer can be an inorganic or organic base. Compositions and transdermal systems are also described.Type: GrantFiled: June 19, 2002Date of Patent: January 6, 2004Assignee: Dermatrends, Inc.Inventors: Eric C. Luo, Nicole T. Gricenko, Tsung-Min Hsu
-
Patent number: 6673365Abstract: A new pharmaceutical formulation comprising the thrombin inhibitor HOOC—CH2—(R)-Cgl-Aze-Pab in combination with medium chain glycerides, a process for the preparation of such a pharmaceutical formulation, the use of a such formulation in the treatment of thromboembolism as well as a method of treating a patient in need of such a treatment by using said formulation.Type: GrantFiled: August 22, 1997Date of Patent: January 6, 2004Assignee: Astra AktiebolagInventors: Jan-Erik Löfroth, Lennart Lindfors, Anna-Lena Ungell
-
Patent number: 6673841Abstract: The present invention relates to a composition of topical preparation containing alprostadil alkyl ester, and more particularly, comprising an alprostadil alkyl ester, an oily vehicle, a skin permeation enhancer and an anti-irritant agent.Type: GrantFiled: December 20, 2001Date of Patent: January 6, 2004Assignee: Whan In Pharm. Co., Ltd.Inventors: Dong Soo Lee, Kye Kwan Lee, Yun Seok Rhee, Jun Hee Jang, Sun Oh Jeoung, Sang Jin Kim, Sang Cheol Chi
-
Patent number: 6667052Abstract: The invention provides a transdermal delivery system for treating diabetes and other pathologic systemic conditions, comprising an active ingredient selected from the group consisting of peptides and proteins having an S—S bond and mixtures thereof and a pharmaceutically acceptable oxidizing agent selected from the group consisting of iodine, povidine-iodine and sources thereof, said system being essentially free of reducing agents and said oxidizing agent enabling and facilitating the penetration of said active ingredient through the skin layers and into the blood stream.Type: GrantFiled: August 10, 2001Date of Patent: December 23, 2003Assignees: Ben Gurion University of the Negev Research and Development AuthorityInventors: Amnon Sintov, Uri Wormser
-
Patent number: 6663874Abstract: A composition for use by animals, including humans, to alleviate pain and/or inflammation around a painful joint, joint replacement surgery site, muscle, tendon, and/or ligament. A method to ameliorate pain and/or inflammation in or around a joint, muscle, tendon, and/or ligament, by topically applying Applicant's composition.Type: GrantFiled: January 19, 2001Date of Patent: December 16, 2003Inventor: Victor Stevens
-
Patent number: 6645520Abstract: A method is provided for increasing the permeability of skin or mucosal tissue to transdermally administered nonsteroidal anti-inflammatory drugs (NSAIDs). The method involves use of a specified amount of a hydroxide-releasing agent, the amount optimized to increase the flux of the NSAID through a body surface while minimizing the likelihood of skin damage, irritation or sensitization. Formulations and drug delivery systems for co-administering a hydroxide-releasing agent with an NSAID are provided as well.Type: GrantFiled: December 14, 2000Date of Patent: November 11, 2003Assignee: Dermatrends, Inc.Inventors: Tsung-Min Hsu, Eric C. Luo
-
Patent number: 6638978Abstract: The present invention discloses an antimicrobial preservative composition and methods of using the same. The antimicrobial preservative composition includes a glycerol fatty acid ester, a binary mixture of fatty acids including a first fatty acid antimicrobial agent selected from fatty acids having about six to about eighteen carbon atoms and a second fatty acid antimicrobial agent selected from fatty acids having about six to about eighteen carbon atoms where the second fatty acid is different from the first fatty acid and a food-grade carrier. Also disclosed is an antimicrobial preservative composition which includes a safe and effective amount of a ethoxylated or propoxylated glycerol fatty acid ester, a binary mixture of fatty acids including a first fatty acid antimicrobial agent selected from this C6 to C18 fatty acids and a second fatty acid antimicrobial agent selected from C6 to C18 fatty acids where the second fatty acid is different from the first fatty acid and a food-grade carrier.Type: GrantFiled: January 26, 1994Date of Patent: October 28, 2003Inventor: Jon J. Kabara
-
Patent number: 6610315Abstract: Disclosed is a composition including a lower alcohol and water in a weight ratio of about 35:65 to 100:0, between at least 0.5% and 8.0% by weight thickener system comprised of at least two emulsifiers, each emulsifier present in at least 0.05% by weight wherein the composition free of auxiliary thickeners has a viscosity of at least 4,000 centipoise at 23° C. and wherein each emulsifier is comprised of at least one hydrophobic group and at least one hydrophilic group. The composition is useful as a presurgical scrub replacement, a lotion or other hand preparation.Type: GrantFiled: February 14, 2002Date of Patent: August 26, 2003Assignee: 3M Innovative Properties CompanyInventors: Matthew T. Scholz, Robert A. Asmus, Jill R. Charpentier
-
Patent number: 6589990Abstract: Therapeutic formulations and methods for treating erectile dysfunction with a misoprostol compound in a subject are provided, a method comprising: obtaining a therapeutic formulation having an effective dose of a misoprostol compound in an excipient carrier; and applying the therapeutic formulation topically to the subject.Type: GrantFiled: February 2, 2000Date of Patent: July 8, 2003Inventors: Panagiotis Kanakaris, Petros Karouzakis
-
Patent number: 6586000Abstract: A method is provided for increasing the permeability of skin or mucosal tissue to topically or transdermally administered pharmacologically or cosmeceutically active agents. The method involves use of a specified amount of a hydroxide-releasing agent, the amount optimized to increase the flux of the active agent through a body surface while minimizing the likelihood of skin damage, irritation or sensitization. Topically applied formulations and drug delivery devices employing hydroxide-releasing agents as permeation enhancers are provided as well.Type: GrantFiled: December 14, 2000Date of Patent: July 1, 2003Assignee: Dermatrends, Inc.Inventors: Eric C. Luo, Eric C. Jacobson, Tsung-Min Hsu
-
Patent number: 6585963Abstract: Nail compositions and methods of use thereof are disclosed. Additionally, nail kits comprising a nail composition and pre-treatment compositions are disclosed. Further, supportive devices such as bandages for use in the administering a nail composition are disclosed. In one aspect of the invention, the nail compositions comprise an antifungal agent, including fluconazole, a non-cellulosic polymeric carrier, and an enhancer, while being substantially free of urea, sulfhydryl-containing amino acids, or vasodilators.Type: GrantFiled: April 10, 2001Date of Patent: July 1, 2003Assignee: Watson Pharmaceuticals, Inc.Inventors: Danyi Quan, Ana Ruiz
-
Patent number: 6565879Abstract: A method is provided for increasing the permeability of skin or mucosal tissue to a topically or transdermally administered pharmacologically or cosmeceutically active peptide, polypeptide or protein. The method involves use of a specified amount of a hydroxide-releasing agent, the amount optimized to increase the flux of the peptide, polypeptide or protein through a body surface while minimizing the likelihood of skin damage, irritation or sensitization. Formulations and drug delivery devices employing hydroxide-releasing agents as permeation enhancers are provided as well.Type: GrantFiled: October 13, 2000Date of Patent: May 20, 2003Assignee: Dermatrends, Inc.Inventors: Eric C. Luo, Eric C. Jacobson, Tsung-Min Hsu
-
Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
Patent number: 6562370Abstract: A method is provided for increasing the permeability of skin or mucosal tissue to transdermally administered steroid drugs. The method involves use of a specified amount of a hydroxide-releasing agent, the amount optimized to increase the flux of the drug through a body surface while minimizing the likelihood of skin damage, irritation or sensitization. Formulations and drug delivery systems for co-administering a hydroxide-releasing agent with a steroid drug are provided as well. Optimally, the steroid drugs are a combination of an estrogen and progestin that may be administered in female hormone replacement therapy, to provide female contraception, and the like.Type: GrantFiled: December 14, 2000Date of Patent: May 13, 2003Assignee: Dermatrends, Inc.Inventors: Eric C. Luo, Tsung-Min Hsu -
Patent number: 6562606Abstract: A method for disrupting epithelial barrier function in a host in need of the topical administration of a physiologically active substance which comprises applying to the epithelium of the host, barrier-disrupting amount of at least one agent selected from the group consisting of an inhibitor of ceramide synthesis, inhibitor of acylceramide synthesis, inhibitor of glucosylceramide synthesis, and inhibitor of sphingomyelin synthesis, an inhibitor of fatty acid synthesis, an inhibitor of cholesterol synthesis, a degradation enzyme of ceramides, acylceramide, glucosylceramides, sphingomyelin, an inhibitor of phospholipid, glycosphingolipid, including glucosylceramide, acylceramide or sphingomyelin degradation, and both inhibitors and stimulators of metabolic enzymes of free fatty acids, ceramide, and cholesterol, as well as a topical composition useful therefor are disclosed.Type: GrantFiled: June 30, 2000Date of Patent: May 13, 2003Assignees: The Regents of the University of California, Cellegy Pharmaceuticals, Inc.Inventors: Peter M. Elias, Kenneth R. Feingold, Walter M. Holleran
-
Patent number: 6562368Abstract: A method is provided for increasing the permeability of skin or mucosal tissue to transdermally administered oxybutynin. The method involves use of a specified amount of a hydroxide-releasing agent, the amount optimized to increase the flux of the drug through a body surface while minimizing the likelihood of skin damage, irritation or sensitization. Formulations, drug delivery systems and methods of treatment are provided as well.Type: GrantFiled: December 14, 2000Date of Patent: May 13, 2003Assignee: Dermatrends, Inc.Inventors: Tsung-Min Hsu, Eric C. Luo
-
Patent number: 6562369Abstract: A method is provided for increasing the permeability of skin or mucosal tissue to transdermally administered androgenic drugs. The method involves use of a specified amount of a hydroxide-releasing agent, the amount optimized to increase the flux of the androgenic drug through a body surface while minimizing the likelihood of skin damage, irritation or sensitization. Formulations and drug delivery systems for co-administering a hydroxide-releasing agent with an androgenic drug are provided as well.Type: GrantFiled: December 14, 2000Date of Patent: May 13, 2003Assignee: Dermatrends, Inc.Inventors: Eric C. Luo, Tsung-Min Hsu
-
Patent number: 6541519Abstract: Methods and compositions are disclosed for prevention and/or treatment of diseases in which 5- and 12-lipoxygenase activity contributes to the pathological condition, by administration of 12-methyletradecanoic acids alone and in conjunction with other therapeutic compounds. Methods to inhibit lipoxygenase-mediated inflammations are disclosed.Type: GrantFiled: April 6, 2001Date of Patent: April 1, 2003Assignee: Coastside Bio ResourcesInventors: Peter D. Collin, Peiying Yang, Robert Newman
-
Patent number: 6514963Abstract: The present invention comprises methods and compositions for use in inhibiting egg production by parasitic trematode worms comprising administering to an individual in need thereof an effective amount of an agent which transiently inhibits the influx of calcium through a cell membrane calcium channel. Inhibition of egg production in the worms ameliorates many of the symptoms and pathology related to infection by trematode related diseases, including Schistosomiasis. The methods can also effect disease transmission by reducing the number of eggs released into the environment available to continue the worm life cycle.Type: GrantFiled: July 18, 2001Date of Patent: February 4, 2003Assignee: The Regents of the University of CaliforniaInventors: Mark Walter, Armand Kuris
-
Patent number: 6486207Abstract: The invention provides a composition suitable for topical application comprising: an effective amount of a prostaglandin, a polymer thickener, a lipophilic component, and a buffer system. In another embodiment, the invention provides a composition suitable for topical application comprising: an effective amount of a vasoactive agent, a polymer thickener, a lipophilic component, and a buffer system. The invention also provides methods of ameliorating female sexual dysfunction. Also provided are methods of increasing female sexual arousal and methods of enhancing female sexual response.Type: GrantFiled: December 10, 1998Date of Patent: November 26, 2002Assignee: NexMed (Holdings), Inc.Inventors: James L. Yeager, Nadir Buyuktimkin, Servet Buyuktimkin
-
Patent number: 6485740Abstract: A methotrexate-containing transdermal preparation effective for rheumatoid arthritis comprises an organic amine. The organic amine may preferably be an alkonolamine such as monoethanolamine, diethanolamine, triethanolamine or diisopropanolamine, or an alkylamine such as ehtylamine, diethylamine or triethylamine. The transdermal preparation is, for example, a plaster, a cataplasm, an ointment, a cream or a lotion.Type: GrantFiled: March 14, 2000Date of Patent: November 26, 2002Assignee: Yutoku Pharmaceutical Ind., Co., Ltd.Inventors: Kenji Tominaga, Takaaki Hamada
-
Patent number: 6465442Abstract: The present invention relates to a compositions and methods for treating tinnitus. In preferred embodiments of the invention, muscurinic and/or opioid agents are administered to the affected ear in amount effective to relieve one or more tinnitus symptoms. A preferred agent is an anticholinesterase inhibitor, such as neoostigmine.Type: GrantFiled: July 17, 2001Date of Patent: October 15, 2002Inventor: George F. El Khoury
-
Patent number: 6461636Abstract: The invention relates to a transdermal therapeutic system (TTS) for the transcutaneous administration of pergolide over several days and to a method for its manufacture without using solvents. The TTS contains a matrix mass, containing pergolide and taking the form of a layer, which contains a (meth)acrylate copolymer containing ammonio groups or a mixture of a (meth)acrylate copolymer containing amino groups and a (meth)acrylate polymer containing carboxyl groups, 10-50% by weight propylene glycol and up to 5% by weight pergolide.Type: GrantFiled: October 10, 2000Date of Patent: October 8, 2002Assignee: Schwarz Pharma AGInventors: Christoph Arth, Andreas Kollmeyer-Seeger, Stephan Rimpler, Hans-Michael Wolff
-
Patent number: 6451815Abstract: The present invention relates to a method of enhancing the bioavailability of a piperidinoalkanol antihistamine in a patient which comprises co-administering to said patient an effective antihistaminic amount of said piperidinoalkanol and an effective p-glycoprotein inhibiting amount of a p-glycoprotein inhibitor.Type: GrantFiled: July 13, 1999Date of Patent: September 17, 2002Assignee: Aventis Pharmaceuticals Inc.Inventors: Kin-Kai Hwang, Dennis H. Giesing, Gail H. Hurst
-
Patent number: 6447820Abstract: The disclosed is a treatment of existing and prevention of new skin scars in humans and animals using a topical application containing alcoholic extracts of Cortex Phellodendri and Opuntia ficus indica in a specific combination.Type: GrantFiled: January 22, 2001Date of Patent: September 10, 2002Inventor: Sarfaraz K Niazi
-
Patent number: 6444234Abstract: Pharmaceutical compositions for the transdermal administration of a medicament or other active agent by topical application of the composition to the skin of humans or other animals are described. Methodology for formulating such compositions which provide for very rapid uptake of the medicament and transmigration into and through the skin to either fatty tissues or the vascular system, while minimizing irritation to the skin and/or immunological response, is based on a transdermal delivery system (TDS) wherein the medicament is modified to form a true solution in a complex formed from particular solvents and solvent and solute modifiers in combination with skin stabilizers. Uptake of the medicament is further facilitated and made more rapid by including Forskolin or other source of cellular energy, namely induction of cAMP or cGMP.Type: GrantFiled: May 11, 2000Date of Patent: September 3, 2002Inventors: Kenneth B Kirby, Berno I. R. Pettersson, Jr.
-
Patent number: 6432383Abstract: A mixed micellar pharmaceutical formulation includes a micellar proteinic pharmaceutical agent, an alkali metal lauryl sulphate, alkali metal salicylate, a pharmaceutically acceptable edetate and at least one absorption enhancing compounds. The absorption enhancing compounds are selected from the group consisting of lecithin, hyaluronic acid, pharmaceutically acceptable salts of hyaluronic acid, octylphenoxypolyethoxyethanol, glycolic acid, lactic acid, chamomile extract, cucumber extract, oleic acid, linolenic acid, borage oil, evening of primrose oil, trihydroxy oxo cholanylglycine, glycerin, polyglycerin, lysine, polylysine, triolein and mixtures thereof. The amount of each absorption enhancing compound is present in a concentration of from 1 to 10 wt./wt. % of the total formulation, and the total concentration of absorption enhancing compounds are less than 50 wt./wt. % of the formulation. A method for administering insulin to the buccal mucosa using a metered dose inhaler is also disclosed.Type: GrantFiled: March 30, 2000Date of Patent: August 13, 2002Assignee: Generex Pharmaceuticals IncorporatedInventor: Pankaj Modi
-
Patent number: 6426080Abstract: The disclosed cosmetic preparation of active substances protects the skin in a particularly effective way against free radical aggression, both alone and in combination with other active substances. The preparation consists of a Quebraco blanco bark extract containing at least 90 wt. % proanthocyanidin oligomers, a silkworm extract containing the peptide cecropin, amino acids and a vitamin mixture, a non-ionic, cationic or anionic hydrogel, phospholipids and water, and may also contain further active substances such as vitamin derivatives and plant extracts of acerola, sea weed, citrus, bitter orange, cherry, papaya, tea, coffee beans, Mimosa tenuiflora and angelica. The preparations have protection factors against free radicals of up to 10000, and the cosmetic compositions containing these preparations have protection factors of between 40 and 200, depending on their proportion of the preparations.Type: GrantFiled: December 22, 2000Date of Patent: July 30, 2002Assignee: Coty, B.V.Inventors: Karin Golz-Berner, Leonhard Zastrow
-
Patent number: 6419939Abstract: A compound for reducing the incidence of pseudofolliculitis combines a mild skin astringent, an oil based epidermal softener, and a hair stiffener. One embodiment of the compound combines refined powdered oatmeal and emollient of the compound combines refined powdered oatmeal and emollient oil, such as mink oil and liquid vitamin A in a petroleum jelly base. The mixture is applied by being massaged into the skin prior to lathering and then again immediately after the rinsing of the face after shaving. Continual usage significantly reduces the eruption of pseudofolliculitis.Type: GrantFiled: May 8, 2001Date of Patent: July 16, 2002Inventor: John Campbell
-
Patent number: 6419913Abstract: This invention relates to a method for enhancing the transmembrane penetration of benefit agents using a certain non-ionic lipid/surfactant-containing formulation as an enhancing agent, and the compositions used therein. Various active agents, such as anti-dandruff agents, hair growth agents, hair inhibitor agents, anti-acne agents, anti-aging agents, depilatory agents, and depigmentation agents, may be effectively delivered into the skin, hair follicles and sebaceous glands using the compositions of the present invention.Type: GrantFiled: July 26, 2001Date of Patent: July 16, 2002Assignee: Johnson & Johnson Consumer Companies, Inc.Inventors: Susan M. Niemiec, Jonas C. T. Wang, Stephen J. Wisniewski, Kurt S. Stenn, Gwang Wei Lu
-
Patent number: 6414028Abstract: A topical composition of a semi-solid consistency suitable is provided for transdermal application of prostaglandin E1. The composition comprises prostaglandin E1, a penetration enhancer, a polysaccharide gum, a lipophilic compound, and an acidic buffer system. The penetration enhancer is an acid addition salt of an alkyl-2-(substituted amino)-alkanoate ester, of a (substituted amino)-alkanol alkanoate, or of a mixture thereof. The lipophilic compound may be an aliphatic C1 to C8 alcohol, an aliphatic C8 to C30 ester, or a mixture of these. The composition includes a buffer system capable of providing a buffered pH value for said composition in the range of about 3 to about 7.4.Type: GrantFiled: April 4, 2000Date of Patent: July 2, 2002Assignee: NexMed Holdings, Inc.Inventors: Servet Büyüktimkin, Nadir Büyüktimkin, James L. Yeager
-
Patent number: 6395765Abstract: Composition which is useful in particular for the treatment and protection of domestic animals which are infested with parasites or are likely to be infested with them, these compositions comprising, in the form of a ready-to-use solution: a) an insecticidal active substance of formula (I), b) a crystallization inhibitor, c) an organic solvent having a dielectric constant of between 10 and 35, preferably of between 20 and 30, d) an organic co-solvent having a boiling point below 100° C., preferably below 80° C., and a dielectric constant of between 10 and 40, preferably of between 20 and 30.Type: GrantFiled: September 25, 1996Date of Patent: May 28, 2002Assignee: MerialInventor: Jean Pierre Etchegaray
-
Patent number: 6375962Abstract: Skin protection agents such as topical compositions which can prevent the passage of toxic chemicals through the skin, such as barrier creams. Formulations may contain hexamethylene tetramine or derivatives or analogues thereof, which react with alkylating agents such as sulfur mustard, and which are suitable for formulation into topical compositions. The formulations additionally may contain perfluorinated polymeric compounds which are effective barrier compounds for a range of toxic chemicals.Type: GrantFiled: January 23, 2001Date of Patent: April 23, 2002Assignee: The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern IrelandInventors: John Jenner, Colin N Smith, Robert P Chilcott, Christopher D Lindsay
-
Patent number: 6375975Abstract: Pharmaceutical compositions comprising a macromolecular pharmaceutical agent in mixed micellar form are disclosed. The mixed micelles are formed from an alkali metal alkyl sulfate, and at least three different micelle-forming compounds as described in the specification. Micelle size ranges between about 1 and 10 nanometers. Methods for making and using the compositions are also disclosed. A preferred method for administering the present composition is through the buccal region of the mouth.Type: GrantFiled: March 6, 2000Date of Patent: April 23, 2002Assignee: Generex Pharmaceuticals IncorporatedInventor: Pankaj Modi
-
Patent number: 6359008Abstract: An acylamino acid for enhancing the bio-availability of substances in organisms by permeabilization of cell membranes, the acylamino acid having general formula (I) wherein R1 is hydrogen, a primary, secondary or tertiary alkyl or alkenyl group and R2 is hydrogen, a straight or branched chain alkyl group or a straight or branched chain substituted alkyl group, the substituted being selected from thio, thioether, hydroxy, carboxy, quarternary ammonium, amide, heterocyclic, benzyl, substituted benzyl, amino, substituted amino groups and difunctional alkyl groups linking to the nitrogen atom. A preferred acylamino acid for incorporating into an animal or fish feed is 2-palmitoylaminoproprionic acid.Type: GrantFiled: November 20, 2000Date of Patent: March 19, 2002Assignee: Lovesgrove Research LimitedInventor: David J. Garnett
-
Patent number: 6348199Abstract: A clear, transparent highly stable skin moisturizing and lubricating composition is provided comprising the product obtained by combining polyglyceryl methacrylate with a pharmaceutically acceptable silicone, in the presence of a suitable emulsifier under application of pressure in the range of about 13,000 to about 50,000 psi. The compositions are adapted for use as cosmetics and/or carriers for active drugs and serve in this form for treatment of skin irritations, burns, skin infections and the like. A method of preparing the compositions of the invention is disclosed. The invention also contemplates methods for lubricating and moisture replenishment of the skin, treating burns, skin infections and the like by topically applying the disclosed skin treatment compositions of the invention.Type: GrantFiled: January 5, 1994Date of Patent: February 19, 2002Inventors: Joseph Vernice, Alfred R. Globus
-
Patent number: 6344211Abstract: A pharmaceutical product for the release of medicinal agents to the skin having absorption-increasing auxiliary agents is characterized in that the auxiliary material forms subcooled melts.Type: GrantFiled: November 21, 2000Date of Patent: February 5, 2002Assignee: LTS Lohmann Therapie-Systeme GmbHInventor: Thomas Hille
-
Patent number: 6335374Abstract: A penetrating concentrate containing a biocidal amount of a biocide uses a penetrating carrier vehicle containing an emulsifiable copolymer of a cyclic diene and a polymerizable, unsaturated glyceride. For biocides, such as iodopropargyl carbamate, which otherwise requires use of significant amounts of co-solvent to disperse, is directly soluble in the copolymer thereby eliminating or at least substantially reducing the need for co-solvents to assure stability of the biocide in the formulation. The concentrate also exhibits a low level of volatile organics.Type: GrantFiled: October 7, 1994Date of Patent: January 1, 2002Assignee: Troy Technology Corporation, Inc.Inventors: Eeva-Liisa Kuusisto, Timothy Savage, Peter Schaeufele, Rudi Moerck
-
Patent number: 6333057Abstract: This invention relates to the topical and oral treatment of hair loss, especially androgenic alopecia, by providing formulations that include anti-androgens, especially extracts of the saw palmetto plant, co-enzyme Q, and acetyl carnitine, and optionally stimulators of adenylate cyclase to stimulate hair growth, to increase the luster of hair, and to decrease hair graying.Type: GrantFiled: July 16, 1998Date of Patent: December 25, 2001Inventor: Wilson T. Crandall
-
Patent number: 6323241Abstract: The invention provides methods of treating erectile dysfunction comprising the step of placing within the fossa navicularis of the patient an effective erection-inducing amount of a prostaglandin E1 composition of a semi-solid consistency. The composition comprises prostaglandin E1, a penetration enhancer, a polysaccharide gum, a lipophilic compound, and an acidic buffer system. The penetration enhancer is an alkyl-2-(N,N-disubstituted amino)-alkanoate ester, an (N,N-disubstituted amino)-alkanol alkanoate, or a mixture of these. The lipophilic compound may be an aliphatic C1 to C8 alcohol, an aliphatic C8 to C30 ester, or a mixture of these. The composition includes a buffer system capable of providing a buffered pH value for said composition in the range of about 3 to about 7.4.Type: GrantFiled: January 10, 2000Date of Patent: November 27, 2001Assignee: NexMed (Holdings) Inc.Inventors: James L. Yeager, Nadir Buyuktimkin, Servet Buyuktimkin
-
Patent number: 6303112Abstract: A wound healant composition comprising a therapeutically effective amount of activated growth factors and ascorbic acid and/or at least one retinoid and/or at least one antibiotic, that facilitates the growth of new tissue.Type: GrantFiled: November 23, 1999Date of Patent: October 16, 2001Inventor: Charles E. Worden
-
Patent number: 6287580Abstract: A self-warming cosmetic composition is provided which delivers skin conditioning agents and is based upon a redox system of iron powder and a catalyst such as charcoal to provide the warmth. The system is activated with moisture and air.Type: GrantFiled: April 26, 2000Date of Patent: September 11, 2001Assignee: Unilever Home & Personal Care USA, a division of Conopco, Inc.Inventors: Robert Edward Gott, Craig Stephen Slavtcheff, Alexander Paul Znaiden, Brian Andrew Crotty
-
Patent number: 6284234Abstract: This invention relates to a method for enhancing the transmembrane penetration of benefit agents using a certain non-ionic lipid/surfactant-containing formulation as an enhancing agent, and the compositions used therein. Various active agents, such as anti-dandruff agents, hair growth agents, hair inhibitor agents, anti-acne agents, anti-aging agents, depilatory agents, and depigmentation agents, may be effectively delivered into the skin, hair follicles and sebaceous glands using the compositions of the present invention.Type: GrantFiled: July 23, 1999Date of Patent: September 4, 2001Assignee: Johnson & Johnson Consumer Companies, Inc.Inventors: Susan M. Niemiec, Jonas C. T. Wang, Stephen J. Wisniewski, Kurt S. Stenn, Gwang Wei Lu
-
Patent number: 6280754Abstract: A dermal topical formulation containing p-menthane-3,8-diol and a whitening component such as arbutin, kojic acid, ellagic acid, ascorbic acid or its derivative, lactic acid, glycolic acid, tartaric acid, and an essence or an absolute extracted from a plant such as labdanum, jasmine and mugwort (T.vulgare). The dermal topical formulation is highly safe and capable of promoting the percutaneous absorption of the whitening component.Type: GrantFiled: November 2, 1999Date of Patent: August 28, 2001Assignee: Takasago International CorporationInventors: Minoru Hanada, Eiko Tamai, Kazuhiko Tokoro
-
Patent number: 6277402Abstract: A method for treatment of multiple sclerosis and related disease states. A histamine H2 mimicking agent is administered in an amount which is effective to stimulate production of a cyclic AMP in the body. A phosphodiesterase inhibitor is administered in conjunction with the histamine H2 mimicking agent to conserve the cyclic AMP which is thus produced. It is believed that the increased cyclic AMP levels serve to maintain the patient's myelin against self degeneration. The histamine H2 mimicking agent may be histamine phosphate and the phosphodiesterase inhibitor may be caffeine. The histamine H2 mimicking agent and the phosphodiesterase inhibitor may be mixed in a gel and administered using a transdermal patch.Type: GrantFiled: June 25, 1999Date of Patent: August 21, 2001Inventor: Elaine Alice DeLack